Detect-Ready MRSA Panel - Rotor Gene Compatible Version - In Vitro Diagnostic Medical Devices ישראל - עברית - Ministry of Health

detect-ready mrsa panel - rotor gene compatible version - in vitro diagnostic medical devices

אלדן ציוד אלקטרוני בע"מ - צוות טכני - בדיקה לאיתור מהיר של סטאפילוקוקוס אוריוס עמיד למתיצילין אצל נשאים של החיידק.

אורלן- ANAGENESE 25+ קרם עיניים ישראל - עברית - Ministry of Health

אורלן- anagenese 25+ קרם עיניים

אפריל רשת חנויות בעמ - שיפור מראה העור

סרוקואל 25 מג ישראל - עברית - Ministry of Health

סרוקואל 25 מג

tzamal pharma - quetiapine as fumarate - טבליות מצופות פילם - quetiapine as fumarate 25 mg - quetiapine - quetiapine - indicated for the treatment of schizophrenia. treatment of manic episodes associated with bipolar disorder.treatment of major depressive episodes in bipolar disorders.

סרוקואל 100 מג ישראל - עברית - Ministry of Health

סרוקואל 100 מג

tzamal pharma - quetiapine as fumarate - טבליות מצופות פילם - quetiapine as fumarate 100 mg - quetiapine - quetiapine - indicated for the treatment of schizophrenia. treatment of manic episodes associated with bipolar disorder. treatment of major depressive episodes in bipolar disorders.

סרוקואל 200 מג ישראל - עברית - Ministry of Health

סרוקואל 200 מג

tzamal pharma - quetiapine as fumarate - טבליות מצופות פילם - quetiapine as fumarate 200 mg - quetiapine - quetiapine - indicated for the treatment of schizophrenia. treatment of manic episodes associated with bipolar disorder.treatment of major depressive episodes in bipolar disorders.

סרוקואל 300 מג ישראל - עברית - Ministry of Health

סרוקואל 300 מג

tzamal pharma - quetiapine as fumarate - טבליות מצופות פילם - quetiapine as fumarate 300 mg - quetiapine - quetiapine - indicated for the treatment of schizophrenia. treatment of manic episodes associated with bipolar disorder.treatment of major depressive episodes in bipolar disorders.

קדואט ® 5/10 ישראל - עברית - Ministry of Health

קדואט ® 5/10

pfizer pharmaceuticals israel ltd - amlodipine as besylate 5 mg; atorvastatin as calcium 10 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.

קדואט ® 5/20 ישראל - עברית - Ministry of Health

קדואט ® 5/20

pfizer pharmaceuticals israel ltd - amlodipine as besylate 5 mg; atorvastatin as calcium 20 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.